{
    "root": "cc52fc26-1efc-4bb8-af96-6a91f9e7342b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "vancomycin hydrochloride"
    },
    "value": "20250313",
    "ingredients": [
        {
            "name": "VANCOMYCIN HYDROCHLORIDE",
            "code": "71WO621TJD"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "D&C RED NO. 28",
            "code": "767IP0Y5NH"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        }
    ],
    "indications": "vancomycin hydrochloride capsules indicated treatment clostridioides difficile-associated diarrhea . vancomycin hydrochloride capsules also used treatment enterocolitis caused staphylococcus aureus ( including methicillin-resistant strains ) adult pediatric patients less 18 years age . limitations parenteral vancomycin effective infections ; therefore , vancomycin hydrochloride capsules must given orally infections . orally administered vancomycin hydrochloride capsules effective types infections . reduce development drug-resistant bacteria maintain effectiveness vancomycin hydrochloride capsules antibacterial drugs , vancomycin hydrochloride capsules used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy .",
    "contraindications": "c. difficile- associated diarrhea : adult patients ( 18 years age greater ) : 125 mg orally 4 times daily 10 days . ( 2.1 ) pediatric patients ( less 18 years age ) : 40 mg/kg 3 4 divided doses 7 10 days . total daily exceed 2 g. ( 2.2 ) staphylococcal enterocolitis : adult patients ( 18 years age greater ) : 500 mg 2 g orally 3 4 divided doses 7 10 days . ( 2.1 ) pediatric patients ( less 18 years age ) : 40 mg/kg 3 4 divided doses 7 10 days . total daily exceed 2 g. ( 2.2 )",
    "warningsAndPrecautions": "vancomycin hydrochloride capsules , usp available : 125 mg * capsules grey cap pink body imprinted `` sal `` cap `` 729 `` body black ink . 250 mg * capsules brown cap brown body imprinted `` sal `` cap `` 730 `` body white ink . strength pack ndc number vancomycin 125 mg blister pack 20 23155-858-78 bottle pack 50 23155-858-25 vancomycin 250 mg blister pack 20 23155-859-78 bottle pack 50 23155-859-25 * equivalent vancomycin . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "hypersensitivity vancomycin ( 4 )",
    "indications_original": "Vancomycin hydrochloride capsules are indicated for the treatment of Clostridioides difficile-associated diarrhea. Vancomycin hydrochloride capsules are also used for the treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. \n                  \n                     Limitations of Use\n                  \n                  \n                     Parenteral administration of vancomycin is not effective for the above infections; therefore, vancomycin hydrochloride capsules must be given orally for these infections.\n                     Orally administered vancomycin hydrochloride capsules are not effective for other types of infections.\n                  \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride capsules and other antibacterial drugs, vancomycin hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications_original": "C.      difficile- associated diarrhea: Adult Patients (18 years      of age or greater):\u00a0 125 mg orally 4 times daily for 10 days. (2.1) Pediatric Patients      (less than 18 years of age): 40 mg/kg in 3 or 4 divided doses for 7 to 10      days. The total daily dosage should not exceed 2 g. (2.2) Staphylococcal      enterocolitis: Adult Patients (18      years of age or greater): 500 mg to 2 g orally in 3 or 4 divided doses for      7 to 10 days. (2.1) Pediatric Patients      (less than 18 years of age): 40 mg/kg in 3 or 4 divided doses for 7 to 10      days. The total daily dosage should not exceed 2 g. (2.2)",
    "warningsAndPrecautions_original": "Vancomycin hydrochloride capsules, USP are available in:\n                  The 125 mg* capsules have a grey cap and pink body imprinted with \"SAL\" on the cap and \"729\" on the body in black ink.\n                  The 250 mg* capsules have a brown cap and brown body imprinted with \"SAL\" on the cap and \"730\" on the body in white ink.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                               Strength\n                              \n                           \n                           \n                               Pack\n                              \n                           \n                           \n                               NDC number\n                              \n                           \n                        \n                        \n                            Vancomycin 125 mg\n                           \n                            Blister pack of 20\n                           \n                            23155-858-78\n                           \n                        \n                        \n                            Bottle pack of 50\n                           \n                            23155-858-25\n                           \n                        \n                        \n                            Vancomycin 250 mg\n                           \n                            Blister pack of 20\n                           \n                            23155-859-78\n                           \n                        \n                        \n                            Bottle pack of 50\n                           \n                            23155-859-25\n                           \n                        \n                     \n                  \n                  *Equivalent to vancomycin.\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted from 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Hypersensitivity to vancomycin (4)"
}